142 related articles for article (PubMed ID: 14683457)
1. DGAT: novel therapeutic target for obesity and type 2 diabetes mellitus.
Subauste A; Burant CF
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):263-70. PubMed ID: 14683457
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of triglyceride synthesis as a treatment strategy for obesity: lessons from DGAT1-deficient mice.
Chen HC; Farese RV
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):482-6. PubMed ID: 15569818
[TBL] [Abstract][Full Text] [Related]
3. DGAT and triglyceride synthesis: a new target for obesity treatment?
Chen HC; Farese RV
Trends Cardiovasc Med; 2000 Jul; 10(5):188-92. PubMed ID: 11282293
[TBL] [Abstract][Full Text] [Related]
4. Methods for synthesis and uses of inhibitors of ghrelin O-acyltransferase inhibitors as potential therapeutic agents for obesity and diabetes.
Costantino L
Expert Opin Ther Pat; 2010 Nov; 20(11):1603-7. PubMed ID: 20939684
[TBL] [Abstract][Full Text] [Related]
5. Beyond triglyceride synthesis: the dynamic functional roles of MGAT and DGAT enzymes in energy metabolism.
Shi Y; Cheng D
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E10-8. PubMed ID: 19116371
[TBL] [Abstract][Full Text] [Related]
6. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat.
Smith SJ; Cases S; Jensen DR; Chen HC; Sande E; Tow B; Sanan DA; Raber J; Eckel RH; Farese RV
Nat Genet; 2000 May; 25(1):87-90. PubMed ID: 10802663
[TBL] [Abstract][Full Text] [Related]
7. Introducing GOAT: a target for obesity and anti-diabetic drugs?
Gualillo O; Lago F; Dieguez C
Trends Pharmacol Sci; 2008 Aug; 29(8):398-401. PubMed ID: 18606462
[TBL] [Abstract][Full Text] [Related]
8. Patent landscape for discovery of promising acyltransferase DGAT and MGAT inhibitors.
Zambre VP; Khamkar SM; Gavhane DD; Khedkar SC; Chavan MR; Pandey MM; Sanap SB; Patil RB; Sawant SD
Expert Opin Ther Pat; 2020 Nov; 30(11):873-896. PubMed ID: 32878484
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of [trans-5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl]acetic acid monobenzenesulfonate (JTT-553), a novel acyl CoA:diacylglycerol transferase (DGAT) 1 inhibitor.
Tomimoto D; Okuma C; Ishii Y; Akiyama Y; Ohta T; Kakutani M; Ohkuma Y; Ogawa N
Biol Pharm Bull; 2015; 38(2):263-9. PubMed ID: 25747985
[TBL] [Abstract][Full Text] [Related]
10. Protein-tyrosine phosphatase 1B as a potential drug target for obesity.
Dadke S; Chernoff J
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):299-304. PubMed ID: 14683461
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic strategies for metabolic diseases: Small-molecule diacylglycerol acyltransferase (DGAT) inhibitors.
Naik R; Obiang-Obounou BW; Kim M; Choi Y; Lee HS; Lee K
ChemMedChem; 2014 Nov; 9(11):2410-24. PubMed ID: 24954424
[TBL] [Abstract][Full Text] [Related]
12. Discovery of orally active carboxylic acid derivatives of 2-phenyl-5-trifluoromethyloxazole-4-carboxamide as potent diacylglycerol acyltransferase-1 inhibitors for the potential treatment of obesity and diabetes.
Qian Y; Wertheimer SJ; Ahmad M; Cheung AW; Firooznia F; Hamilton MM; Hayden S; Li S; Marcopulos N; McDermott L; Tan J; Yun W; Guo L; Pamidimukkala A; Chen Y; Huang KS; Ramsey GB; Whittard T; Conde-Knape K; Taub R; Rondinone CM; Tilley J; Bolin D
J Med Chem; 2011 Apr; 54(7):2433-46. PubMed ID: 21413799
[TBL] [Abstract][Full Text] [Related]
13. Increased insulin and leptin sensitivity in mice lacking acyl CoA:diacylglycerol acyltransferase 1.
Chen HC; Smith SJ; Ladha Z; Jensen DR; Ferreira LD; Pulawa LK; McGuire JG; Pitas RE; Eckel RH; Farese RV
J Clin Invest; 2002 Apr; 109(8):1049-55. PubMed ID: 11956242
[TBL] [Abstract][Full Text] [Related]
14. Lipogenic enzymes as therapeutic targets for obesity and diabetes.
Lenhard JM
Curr Pharm Des; 2011; 17(4):325-31. PubMed ID: 21375498
[TBL] [Abstract][Full Text] [Related]
15. Diacylglycerol acyltransferases: Potential roles as pharmacological targets.
Zammit VA; Buckett LK; Turnbull AV; Wure H; Proven A
Pharmacol Ther; 2008 Jun; 118(3):295-302. PubMed ID: 18508126
[TBL] [Abstract][Full Text] [Related]
16. Increased diacylglycerol acyltransferase activity is associated with triglyceride accumulation in tissues of diet-induced insulin-resistant hyperlipidemic hamsters.
Casaschi A; Maiyoh GK; Adeli K; Theriault AG
Metabolism; 2005 Mar; 54(3):403-9. PubMed ID: 15736121
[TBL] [Abstract][Full Text] [Related]
17. Coenzyme A: diacylglycerol acyltransferase 1 inhibitor ameliorates obesity, liver steatosis, and lipid metabolism abnormality in KKAy mice fed high-fat or high-carbohydrate diets.
Yamamoto T; Yamaguchi H; Miki H; Shimada M; Nakada Y; Ogino M; Asano K; Aoki K; Tamura N; Masago M; Kato K
Eur J Pharmacol; 2010 Aug; 640(1-3):243-9. PubMed ID: 20478303
[TBL] [Abstract][Full Text] [Related]
18. A novel coenzyme A:diacylglycerol acyltransferase 1 inhibitor stimulates lipid metabolism in muscle and lowers weight in animal models of obesity.
Yamamoto T; Yamaguchi H; Miki H; Kitamura S; Nakada Y; Aicher TD; Pratt SA; Kato K
Eur J Pharmacol; 2011 Jan; 650(2-3):663-72. PubMed ID: 21034741
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a novel series of benzimidazole derivatives as diacylglycerol acyltransferase inhibitors.
Lee K; Goo JI; Jung HY; Kim M; Boovanahalli SK; Park HR; Kim MO; Kim DH; Lee HS; Choi Y
Bioorg Med Chem Lett; 2012 Dec; 22(24):7456-60. PubMed ID: 23141914
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of diacylglycerol acyltransferase by alkamides isolated from the fruits of Piper longum and Piper nigrum.
Lee SW; Rho MC; Park HR; Choi JH; Kang JY; Lee JW; Kim K; Lee HS; Kim YK
J Agric Food Chem; 2006 Dec; 54(26):9759-63. PubMed ID: 17177498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
